Foamy Virus Vectors Expressing Anti-HIV Transgenes Efficiently Block HIV-1 Replication
Open Access
- 1 January 2008
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 16 (1) , 46-51
- https://doi.org/10.1038/sj.mt.6300335
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Gene transfer in humans using a conditionally replicating lentiviral vectorProceedings of the National Academy of Sciences, 2006
- Foamy virus–mediated gene transfer to canine repopulating cellsBlood, 2006
- Impact of gene-modified T cells on HIV infection dynamicsJournal of Theoretical Biology, 2006
- Selective survival of peripheral blood lymphocytes in children with HIV-1 following delivery of an anti-HIV gene to bone marrow CD34+ cellsMolecular Therapy, 2005
- Current status of gene therapy strategies to treat HIV/AIDSMolecular Therapy, 2005
- Anti-Human Immunodeficiency Virus Hematopoietic Progenitor Cell-Delivered Ribozyme in a Phase I Study: Myeloid and Lymphoid Reconstitution in Human Immunodeficiency Virus Type-1–Infected PatientsHuman Gene Therapy, 2004
- Comparison of Three Retroviral Vector Systems for Transduction of Nonobese Diabetic/Severe Combined Immunodeficiency Mice Repopulating Human CD34+Cord Blood CellsHuman Gene Therapy, 2003
- Inhibition of HIV-1 replication by novel lentiviral vectors expressing transdominant Rev and HIV-1 env antisenseGene Therapy, 2002
- Historical Perspective of Foamy Virus Epidemiology and InfectionClinical Microbiology Reviews, 2001
- Stable expression of transdominant Rev protein in human T cells inhibits human immunodeficiency virus replication.The Journal of Experimental Medicine, 1992